These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 15853623)

  • 1. Therapy for neurocysticercosis.
    Takayanagui OM
    Expert Rev Neurother; 2004 Jan; 4(1):129-39. PubMed ID: 15853623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical management of neurocysticercosis.
    Takayanagui OM; Odashima NS; Bonato PS; Lima JE; Lanchote VL
    Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial.
    Kaur S; Singhi P; Singhi S; Khandelwal N
    Pediatr Infect Dis J; 2009 May; 28(5):403-6. PubMed ID: 19325515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Praziquantel therapy in neurocysticercosis.
    Gogna A
    J Assoc Physicians India; 1996 Feb; 44(2):149. PubMed ID: 10999076
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic efficacy of praziquantel, albendazole and a combination of the two drugs in cysticercosis].
    Guo DM; Xie SP; Jia JP
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2003; 21(3):187-8. PubMed ID: 14628357
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug treatment of neurocysticercosis.
    Garg RK
    Natl Med J India; 1997; 10(4):173-7. PubMed ID: 9325640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One week versus four weeks of albendazole therapy for neurocysticercosis in children: a randomized, placebo-controlled double blind trial.
    Singhi P; Dayal D; Khandelwal N
    Pediatr Infect Dis J; 2003 Mar; 22(3):268-72. PubMed ID: 12634590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic optimisation of the treatment of neurocysticercosis.
    Sotelo J; Jung H
    Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts.
    Proaño JV; Madrazo I; Avelar F; López-Félix B; Díaz G; Grijalva I
    N Engl J Med; 2001 Sep; 345(12):879-85. PubMed ID: 11565520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical management of neurocysticercosis.
    Garg RK
    Neurol India; 2001 Dec; 49(4):329-37. PubMed ID: 11799403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of neurocysticercosis: is it beneficial?
    Garg RK
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):435-40. PubMed ID: 18662110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocysticercosis in a European traveler returning from India primarily suspected as neoplasia.
    Salzer HJ; Hoenigl M; Valentin T; Zollner-Schwetz I; Krause R
    J Travel Med; 2013; 20(5):333-5. PubMed ID: 23992578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy of cysticercosis. Review about its pharmacokinetics and toxicology].
    Herrera LA; Benítez-Bribiesca L; Sotelo J; Ostrosky-Wegman P
    Gac Med Mex; 2000; 136(5):477-89. PubMed ID: 11080931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of medical treatment of neurocysticercosis: a study of 65 cases in Cheju Island, Korea.
    Kim SK; Wang KC; Paek SH; Hong KS; Cho BK
    Surg Neurol; 1999 Dec; 52(6):563-9. PubMed ID: 10660021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current approaches to cysticidal drug therapy for neurocysticercosis.
    Del Brutto OH
    Expert Rev Anti Infect Ther; 2020 Aug; 18(8):789-798. PubMed ID: 32331507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic approach to neurocysticercosis].
    Canak G; Ilić A
    Med Pregl; 1998; 51 Suppl 1():57-60. PubMed ID: 9769658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short course of albendazole therapy for neurocysticercosis.
    Alarcón F; Maldonado JC
    Clin Neurol Neurosurg; 2006 Dec; 108(8):810-1. PubMed ID: 16647198
    [No Abstract]   [Full Text] [Related]  

  • 18. [About an autochtonous case of neurocysticercosis in Mali].
    Maïga Y; Diallo M; Bouteille B; Konate A; Diarra M; Maïga M; Marjolet M
    Bull Soc Pathol Exot; 2009 Oct; 102(4):211-4. PubMed ID: 19950534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.
    Garcia HH; Gonzales I; Lescano AG; Bustos JA; Zimic M; Escalante D; Saavedra H; Gavidia M; Rodriguez L; Najar E; Umeres H; Pretell EJ;
    Lancet Infect Dis; 2014 Aug; 14(8):687-695. PubMed ID: 24999157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis.
    Göngora-Rivera F; Soto-Hernández JL; González Esquivel D; Cook HJ; Márquez-Caraveo C; Hernández Dávila R; Santos-Zambrano J
    Neurology; 2006 Feb; 66(3):436-8. PubMed ID: 16382035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.